Literature DB >> 28064059

PAR1 activation affects the neurotrophic properties of Schwann cells.

Elena Pompili1, Cinzia Fabrizi2, Francesca Somma2, Virginia Correani3, Bruno Maras3, Maria Eugenia Schininà3, Viviana Ciraci2, Marco Artico4, Francesco Fornai5, Lorenzo Fumagalli2.   

Abstract

Protease-activated receptor-1 (PAR1) is the prototypic member of a family of four G-protein-coupled receptors that signal in response to extracellular proteases. In the peripheral nervous system, the expression and/or the role of PARs are still poorly investigated. High PAR1 mRNA expression was found in the rat dorsal root ganglia and the signal intensity of PAR1 mRNA increased in response to sciatic nerve transection. In the sciatic nerve, functional PAR1 receptor was reported at the level of non-compacted Schwann cell myelin microvilli of the nodes of Ranvier. Schwann cells are the principal population of glial cells of the peripheral nervous system which myelinate axons playing an important role during axonal regeneration and remyelination. The present study was undertaken in order to determine if the activation of PAR1 affects the neurotrophic properties of Schwann cells. Our results suggest that the stimulation of PAR1 could potentiate the Schwann cell ability to favour nerve regeneration. In fact, the conditioned medium obtained from Schwann cell cultures challenged with a specific PAR1 activating peptide (PAR1 AP) displays increased neuroprotective and neurotrophic properties with respect to the culture medium from untreated Schwann cells. The proteomic analysis of secreted proteins in untreated and PAR1 AP-treated Schwann cells allowed the identification of factors differentially expressed in the two samples. Some of them (such as macrophage migration inhibitory factor, matrix metalloproteinase-2, decorin, syndecan 4, complement C1r subcomponent, angiogenic factor with G patch and FHA domains 1) appear to be transcriptionally regulated after PAR1 AP treatment as shown by RT-PCR.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Peripheral nervous system; Protease-activated receptor-1; Regeneration; Schwann cells

Mesh:

Substances:

Year:  2017        PMID: 28064059     DOI: 10.1016/j.mcn.2017.01.001

Source DB:  PubMed          Journal:  Mol Cell Neurosci        ISSN: 1044-7431            Impact factor:   4.314


  6 in total

1.  Thrombin in peripheral nerves: friend or foe?

Authors:  Elena Pompili; Cinzia Fabrizi
Journal:  Neural Regen Res       Date:  2021-06       Impact factor: 5.135

Review 2.  Role of the protease-activated receptor 1 in regulating the function of glial cells within central and peripheral nervous system.

Authors:  Elena Pompili; Cinzia Fabrizi; Francesco Fornai; Lorenzo Fumagalli
Journal:  J Neural Transm (Vienna)       Date:  2019-09-06       Impact factor: 3.575

Review 3.  The neuro-glial coagulonome: the thrombin receptor and coagulation pathways as major players in neurological diseases.

Authors:  Shany G Gofrit; Efrat Shavit-Stein
Journal:  Neural Regen Res       Date:  2019-12       Impact factor: 5.135

Review 4.  Protease Activated Receptor 1 and Its Ligands as Main Regulators of the Regeneration of Peripheral Nerves.

Authors:  Elena Pompili; Valerio De Franchis; Claudia Giampietri; Stefano Leone; Elena De Santis; Francesco Fornai; Lorenzo Fumagalli; Cinzia Fabrizi
Journal:  Biomolecules       Date:  2021-11-10

Review 5.  Emerging Role of Neuron-Glia in Neurological Disorders: At a Glance.

Authors:  Md Mominur Rahman; Md Rezaul Islam; Md Yamin; Md Mohaimenul Islam; Md Taslim Sarker; Atkia Farzana Khan Meem; Aklima Akter; Talha Bin Emran; Simona Cavalu; Rohit Sharma
Journal:  Oxid Med Cell Longev       Date:  2022-08-22       Impact factor: 7.310

6.  Treatment of Diabetic Neuropathy with A Novel PAR1-Targeting Molecule.

Authors:  Efrat Shavit-Stein; Shany Guly Gofrit; Alexandra Gayster; Yotam Teldan; Ariel Ron; Eiman Abu Bandora; Valery Golderman; Orna Gera; Sagi Harnof; Joab Chapman; Amir Dori
Journal:  Biomolecules       Date:  2020-11-13
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.